tiprankstipranks
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
US Market
SCNI
Scinai Immunotherapeutics
RESEARCH TOOLSreports
Want to see SCNI full AI Analyst Report?

Scinai Immunotherapeutics (SCNI) Income Statement

340 Followers

Scinai Immunotherapeutics Income Statement

Last quarter (Q2 2025), Scinai Immunotherapeutics's total revenue was $386.50K, an increase of 36.09% from the same quarter last year. In Q2, Scinai Immunotherapeutics's net income was $-2.07M. See Scinai Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Dec 21
Total Revenue
$ 1.31M$ 658.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.65M$ -580.00K$ -512.67K$ -559.80K$ -747.65K
Operating Expenses
$ 4.89M$ 8.06M$ 9.71M$ 11.06M$ 10.86M
Depreciation and Amortization
$ 1.42M$ 1.65M$ 514.00K$ 562.00K$ 471.00K
EBITDA
$ -6.53M$ -6.99M$ -9.19M$ -10.50M$ -10.39M
Operating Income
$ -7.54M$ -8.64M$ -9.71M$ -11.06M$ -10.87M
Other Income/Expenses
$ -765.00K$ 13.43M$ 3.21M$ 5.26M$ 2.67M
Pretax Income
$ -8.31M$ 4.80M$ -6.50M$ -5.80M$ -8.21M
Net Income
$ -8.31M$ 4.80M$ -6.50M$ -5.80M$ -8.21M
Per Share Metrics
Basic EPS
$ -3.60$ 6.00$ -16.80$ -30.80$ -80.00
Diluted EPS
$ -3.60$ 6.00$ -16.80$ -30.80$ -80.00
Weighted Average Shares Outstanding
 2.33M 806.37K 390.66K 188.52K 102.57K
Weighted Average Shares Outstanding (Diluted)
 2.33M 806.37K 390.66K 188.52K 141.14K
Currency in USD

Scinai Immunotherapeutics Earnings and Revenue History